Undifferentiated Ovarian Carcinoma Active Not Recruiting Phase 3 Trials for Paclitaxel (DB01229)

IndicationStatusPhase
DBCOND0028876 (Undifferentiated Ovarian Carcinoma)Active Not Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00565851Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube CancerTreatment
NCT00108745Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube CancerTreatment